Market Overview - The A-share market has experienced a strong upward trend in January, frequently reaching new highs, with significant investor participation and enthusiasm [1][14] - As the market approaches the 4100-point threshold, it has entered a phase of high-level fluctuations, with signs of adjustment in certain sectors and intensified competition between bulls and bears [1][14] Economic Outlook for 2026 - The macroeconomic environment is expected to maintain a recovery trend, with gradual improvement in corporate earnings and continued ample liquidity [3][16] - The domestic and international technology sectors are expected to resonate, with emerging industries showing rapid growth and China's manufacturing competitiveness expanding [3][16] - Long-term market support is anticipated from the execution of the "14th Five-Year Plan," the advancement of RMB internationalization, and policies encouraging long-term capital inflows [3][16] Sector Focus - **Technology Manufacturing**: Continued optimism, shifting focus from upstream to downstream AI applications, particularly in smart driving, robotics, AI wearables, and AI healthcare [5][18] - **Lithium Battery Storage**: Short-term performance affected by surging upstream material prices, but long-term prospects remain strong due to China's manufacturing advantages [5][18] - **Automotive Sector**: Significant changes expected in 2026, with a stark divide; companies closely related to AI and smart technologies are likely to perform well, while those lagging in smartization may face challenges [5][18] Consumer Sector Insights - 2026 is projected to be a pivotal year for the consumer sector, driven by anticipated increases in household income, moderate price recoveries, and historically low valuations and market capitalizations [10][23] - "Old consumption" is expected to transition from defense to offense, with improved competitive dynamics and returns for leading companies [10][23] - "New consumption" emphasizes selective investment in companies with strong competitive positions amid a challenging competitive landscape [10][23] Pharmaceutical Sector Analysis - The innovative drug sector is expected to present opportunities, driven by unique market positioning and significant growth potential [11][24] - The emergence of new categories such as brain-computer interfaces and medical AI is noted, indicating a shift towards meeting previously unmet needs in the market [11][24] Investment Themes - The core investment logic for 2026 is centered around "AI + hard capabilities," encompassing sectors such as smart driving, consumer electronics, robotics, industrial processes, communication, energy management, and commercial aviation [8][21] - AI applications are anticipated to enhance efficiency and reduce costs across various industries, including manufacturing and communication [8][22] Hong Kong Market Perspective - Despite some valuation recovery in 2025, the Hong Kong market remains undervalued compared to major global markets, with expectations for rapid earnings recovery based on low baselines [12][25] - The downward trend in ERP is anticipated to continue, influenced by industry structure, investor dynamics, and RMB internationalization [12][25]

Core Insights - BlackRock's Bitcoin spot ETF, IBIT, reached a record trading volume of over 284 million shares, with a nominal value exceeding $10 billion, marking a 169% increase from the previous record [1][6] - The price of IBIT fell by 13% to around $36, the lowest since October 2024, with a year-to-date decline of 27% [1][6] Trading Volume and Price Dynamics - The trading volume of IBIT on Thursday was nearly double the previous record of 169 million shares set on November 21 [6] - The price of IBIT dropped to a low of $35, down from a peak of $71.82 in early October last year, indicating a significant bearish trend [6] - The combination of record trading volume and price drop is often interpreted as a capitulation sell-off, suggesting that long-term holders are liquidating their positions [6] Redemption and Market Sentiment - On the same day, redemptions for IBIT reached $175 million, accounting for 40% of the total net outflow of $434 million from 11 Bitcoin ETFs [3] - The options market showed heightened fear, with put options trading at a premium over call options by more than 25 volatility points, a historical high [3][6] Speculation on Hedge Fund Activity - Speculation arose regarding the volatility being driven by large positions held by non-crypto hedge funds, which may have been forced to liquidate due to high leverage [7] - The market pressure was exacerbated by simultaneous declines in Bitcoin and stocks, alongside low clearing volumes on centralized finance platforms [7] - The unusual trading activity in IBIT may reflect the stress faced by institutional investors in the current market environment [7]

Core Insights - The article discusses the performance of actively managed equity funds established in 2021, revealing that over 50% of these funds have not returned to their initial investment levels, despite the A-share market being above 4000 points [1] - A total of 667 actively managed equity funds were analyzed, with approximately 362 funds showing negative returns since inception, including 86 funds with declines exceeding 30% and 34 funds with declines over 40% [1] - Specific funds such as Jin Yuan Shun An Medical Health and others have experienced significant losses, with some funds showing declines of over 50% since their inception [1] Fund Performance Summary - Jin Yuan Shun An Medical Health Mixed A/C, established on July 29, 2021, has reported a cumulative return of -57.76% and -58.15% as of February 5, 2026, with multiple changes in fund management [2] - The fund's recent performance includes a 1-year return of 4.81% and a 3-year return of -47.55%, indicating a significant underperformance since its inception [2] - The fund's current scale is approximately 0.16 billion yuan as of December 31, 2025, and it is classified as a mixed equity fund with medium to high risk [2] Fund Manager Changes - The fund has undergone several management changes, with the latest managers being Chen Mingjie and Zhang Haidong, who have not achieved profitable returns during their tenure [3][4] - The performance of the fund managers during their respective tenures has been negative, with returns of -9.20% and -21.02% for the most recent managers [4] - The top ten holdings of the fund as of the fourth quarter of 2025 include companies like Sanofi, Bai Li Tian Heng, and others, indicating a focus on the healthcare sector [4]

Group 1 - The southbound capital has significantly increased, with a cumulative net purchase exceeding 41.2 billion HKD, including net purchases of over 13.3 billion HKD and 24.9 billion HKD on February 4 and 5, respectively, marking a new high since September 2025 [1] - Current global dollar cycle is at a peak decline, and the RMB has transitioned from depreciation to a mild appreciation phase, combined with foreign capital inflow and a shift from valuation recovery to profit-driven growth, suggesting a favorable re-pricing window for Chinese equity assets [1] - Despite recent fluctuations in the Hong Kong tech sector, funds are actively positioning through ETFs, with the Hang Seng Tech ETF (513130) seeing a net inflow of over 3.1 billion HKD in the past four trading days, contributing to an increase in its latest share count to 67.5 billion [1] Group 2 - The Hang Seng Tech ETF (513130) is a key product for investing in the Hong Kong tech sector, tracking the Hang Seng Tech Index, which includes competitive and high-potential tech companies in areas like internet, mobile payments, cloud computing, AI, and semiconductors, currently valued at a low percentile of 29.23% over the past five years [2] - The ETF supports intraday T+0 trading, with a low annual management fee of 0.2%, potentially enhancing investment efficiency and reducing costs for investors [2] - The fund manager, Huatai-PB Fund, is one of the first ETF managers in China, with a strong track record in industry ETFs and broad-based, dividend-themed indices, offering a range of products that may serve as defensive options in a "barbell strategy" [2]

Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (Southern, 159297) experienced a decline of 1.24% on February 5, with a trading volume of 48.6647 million yuan [1] - The fund's shares increased by 2 million, bringing the total shares to 2.023 billion, with a total increase of 161 million shares over the last 20 trading days [1] - The latest net asset value is calculated at 1.633 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs (adjusted for valuation exchange rates) [1] - The fund is managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -19.30%, with a return of -2.93% over the past month [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 重要提示 1、永赢国证港股通互联网交易型开放式指数证券投资基金（以下简称"本基金"）的募集已于2025年12 月24日获中国证监会证监许可〔2025〕2957号文注册。中国证监会对本基金募集申请的注册，并不表明 其对本基金的投资价值、市场前景和收益做出实质性判断或保证，也不表明投资于本基金没有风险。 2、本基金是交易型开放式、股票型证券投资基金、指数基金。 3、本基金的基金管理人为永赢基金管理有限公司（以下简称"本公司"或"永赢基金"），基金托管人为 兴业银行股份有限公司，本基金的登记结算机构为中国证券登记结算有限责任公司。 4、本基金募集对象为符合法律法规规定的可投资于证券投资基金的个人投资者、机构投资者、合格境 外投资者以及法律法规或中国证监会允许购买证券投资基金的其他投资人。个人投资者指依据有关法律 法规规定可投资于证券投资基金的自然人；机构投资者指依法可以投资证券投资基金的、在中华人民共 和国境内合法登记并存续或经有关政府部门批准设立并存续的企业法人、事业法人、社会团体或其他组 织；合格境外投资者指符合《合格境外机构投资者和人民币合格境外机构投资者境内 ...

Group 1 - The company, Bank of China Investment Management Co., Ltd., will adjust the minimum subscription and additional subscription amounts for its Zhongyin Fengqing Regular Open Bond Fund (Fund Code: 003770) starting from February 6, 2026 [1][5] - After the adjustment, the minimum subscription amount for first-time investors through the company's electronic direct sales platform will be RMB 1,000, and for additional subscriptions, it will be RMB 10. For subscriptions through the company's direct sales center, the minimum will be RMB 10,000 for first-time and RMB 1,000 for additional subscriptions [2][6] - Sales institutions may adjust the minimum subscription amounts based on their circumstances, and investors must adhere to the relevant regulations of the sales institutions [2][7] Group 2 - The company will also adjust the minimum subscription and additional subscription amounts for its Zhongyin Fengrong Regular Open Bond Fund (Fund Code: 004882) effective February 6, 2026 [5][10] - For this fund, the minimum subscription amount through the company's direct sales center will be RMB 1,000 for first-time and RMB 10 for additional subscriptions. Through designated sales institutions, the minimum will be RMB 1,000 for first-time and RMB 1 for additional subscriptions [6][11] - This fund is not publicly sold to individual investors [8][12] Group 3 - The company will adjust the minimum subscription and additional subscription amounts for its Zhongyin Fengrun Regular Open Bond Fund (Fund Code: 003832) starting February 6, 2026 [10][14] - For this fund, the minimum subscription amount through the company's direct sales center will be RMB 1,000 for first-time and RMB 10 for additional subscriptions. Through designated sales institutions, the minimum will be RMB 1,000 for first-time and RMB 10 for additional subscriptions [11][13] - This fund is also not publicly sold to individual investors [12][13]

Core Viewpoint - E Fund Management Co., Ltd. has announced changes regarding the calculation of the Indicative Optimized Portfolio Value (IOPV) for three of its ETFs, effective February 9, 2026, shifting the calculation responsibility from the Shanghai Stock Exchange to the fund manager or an institution designated by the fund manager [1][4]. Group 1: Fund Involved - The fund affected by the contract revision is the E Fund CSI Mid-Cap ETF, which will have its IOPV calculation institution changed as stated [1]. - The fund contract will be amended to reflect that the IOPV calculation and announcement details will be found in the fund's prospectus [1]. Group 2: Contract and Prospectus Revisions - The revisions to the fund contract are in compliance with relevant laws and regulations, ensuring no substantial adverse impact on the interests of fund shareholders [5]. - The prospectuses for the E Fund CSI 50 ETF and the E Fund STAR Market 50 ETF will also be updated to reflect the change in the IOPV calculation institution [3]. Group 3: Additional Information - The changes to the fund contract and prospectus will take effect on February 9, 2026 [4]. - Investors can consult the fund's sales institutions or the company's website for further details regarding the changes [9][10].

Group 1 - The announcement date for the fund is February 6, 2026 [1] - The fund manager's senior management and heads of investment and research departments have subscribed to 0 shares of the fund [1] - The fund manager will officially start managing the fund from the effective date of the fund contract [1] Group 2 - Southwest Securities Co., Ltd. has been added as a primary dealer for certain exchange-traded open-end funds managed by the company starting February 6, 2026 [4] - Investors can conduct subscription and redemption transactions through Southwest Securities [4] - Contact information for Southwest Securities includes an address in Chongqing and a customer service number [5]

Announcement Information - The fund will suspend subscription, regular investment, and conversion-in services from February 12, 2026, for distribution agencies and from February 13, 2026, for direct sales agencies due to the holiday schedule [1][6][10] - The fund will resume these services on February 24, 2026, without further announcement [1][6][10] - Applications for account opening, subscription, redemption, etc., submitted between February 14 and February 23, 2026, will be processed on February 24, 2026 [1][6][10] - Investors are advised to consider the time required for fund transactions and submit redemption requests in advance to avoid inconvenience during the holiday [1][6][10] Additional Information - Investors can find detailed information about the fund on the management company's website and can contact customer service for inquiries [2][7][11]